In Vivo Models

More than 100 validated infection models, each customized to your compound and endpoints. When in vitro data shows promise, this is where it becomes biological proof.

The Efficacy Layer

Translating Bench Activity Into Biological Proof

Our in vivo models span nearly every anatomical site and infection type relevant to antimicrobial development. Each is run in our AAALAC-accredited facility and tailored to your compound, route, dosing, and readouts.

Select a model below, or talk to us about developing one you don’t see listed. Pharmacokinetic profiling, blood chemistry, tissue harvests, and histopathology are available as add-ons to any in vivo study.

Respiratory
Pulmonary Infection Model

Acute and chronic lung infection models for evaluating compounds against respiratory pathogens.

Learn more →
Systemic
Bacteremia Model

Bloodstream infection models measuring systemic bacterial burden and survival.

Learn more →
Systemic
Fungemia Model

Disseminated fungal infection models for antifungal efficacy evaluation.

Learn more →
Systemic
Cecal Litigation and Puncture (CLP) Model

Cecal ligation and puncture polymicrobial sepsis for severe systemic infection.

Learn more →
Abdominal
Peritonitis Model

Intra-abdominal infection models for rapid efficacy screening.

Learn more →
Urinary
Urinary Tract Infection (UTI) Model

Ascending UTI models evaluating activity against uropathogens.

Learn more →
Bone
Osteomyelitis Model

Bone infection models for compounds targeting deep-seated, hard-to-treat infections.

Learn more →
Skin & Wound
Deep Wound Infection Model

Wound models assessing efficacy in soft-tissue and surgical-site infection.

Learn more →
Skin & Wound
Intradermal Infection Model

Localized dermal infection models for topical and systemic agents.

Learn more →
Skin & Wound
Abrasion Model

Surface skin infection models for evaluating topical antimicrobials.

Learn more →
Skin & Wound
Tape-Stripping Model

Compromised skin-barrier infection models.

Learn more →
Specialty
Otitis Media Model

Middle-ear infection models for compounds targeting ENT indications.

Learn more →
Specialty
Intracranial Infection Model

CNS infection models for compounds that must cross into the brain.

Learn more →
Specialty
Soft Tissue Infection Model

Deep soft-tissue infection models across multiple anatomical sites.

Learn more →
Specialty
Gastrointestinal Infection Model

GI infection models, including C. difficile-associated disease.

Learn more →
Parasitic
Chagas Disease Model

In vivo models for Trypanosoma cruzi and antiparasitic compound evaluation.

Learn more →
Skin & Wound
Abscess Model

Localized abscess models for evaluating activity against contained, purulent infection.

Learn more →
Specialty
Biofilm Model

In vivo biofilm models for surface-associated, highly resistant infection.

Learn more →
Specialty
Intravaginal Infection

Mucosal infection models for genitourinary and reproductive-tract pathogens.

Learn more →

Don’t see the model you need?

Ask Us About Custom Model Development

Ready to discuss your program?
Let's start a conversation.

Request a Quote